NOT MEDICAL ADVICE

BPC-157 + TB-500 Blend

Estimated Market Price
$159.99 $174.99
Based on verified supplier pricing for research-grade compounds
The ultimate recovery stack in one vial. BPC-157 and TB-500 combined for maximum tissue repair and healing synergy.
How it works

Pairs BPC-157's ability to boost blood flow and protect the gut with TB-500's talent for mobilizing repair cells and reducing scar tissue. The two peptides cover complementary healing pathways.

Stacks & Bundles

bestseller

What to Expect
Days 1–3 Dual-pathway activation; initial inflammatory modulation. Mild warmth at injection site; nothing dramatic yet.
Week 1–2 Synergistic healing response; pain and swelling reducing. Pain reducing faster than expected; swelling going down.
Week 3–4 Accelerated tissue remodeling beyond single-peptide protocols. Healing feels accelerated; moving much more easily.
Week 5–6 Advanced structural repair; mobility significantly improved. Injuries feel significantly repaired; confidence in body returning.
Week 7–8 Peak synergistic benefits; evaluate for protocol completion. Near complete recovery; back to full activity.

Verified Suppliers

For research purposes only. These suppliers have been independently verified by PepSpace. We do not process sales directly.

PepSpace is not affiliated with any listed supplier
Protocol & Dosage
Typical Dosage 250–500 mcg/day SC (combined dose)
Administration Subcutaneous injection
Schedule Once daily, AM on empty stomach
Protocol Duration 4–8 weeks
Half-Life Varies by component
Side Effects & Safety
Tolerability Profile Mild

Generally well tolerated; side effects are mild and transient

Common Side Effects

  • Injection site warmth or rednessmost users
  • Mild GI discomfortsome users

Less Common

  • Temporary fatigueoccasional
  • Headacheoccasional
  • Mild nauseaoccasional
  • Localized swelling near injectionoccasional

Discontinue If

  • Severe allergic reaction (rash, breathing difficulty)
  • Persistent GI bleeding or dark stools
  • Unusual bruising or swelling beyond injection site

Contraindications

  • Pregnancy or breastfeeding
  • Active cancer or tumors
  • Known hypersensitivity to either component

Data note: Safety profile reflects both components. No controlled combination studies exist; inferred from individual compound data.

Always consult a qualified healthcare professional before use. This information is for research reference only and does not constitute medical advice.

Ask about BPC-157 + TB-500 Blend
Send us a message

Call us
+1 (518) 327-4392
Business hours
Monday – Friday 9:00 AM – 6:00 PM EST
Saturday 10:00 AM – 2:00 PM EST
Sunday Closed

You can also reach us via or .

How to Apply

1

Gather

Peptide vial, BAC water, alcohol swabs, insulin syringe

2

Sanitize

Wipe tops of both vials with alcohol swabs

3

Draw

Pull 1–2 mL of BAC water into syringe

4

Add Water

Release water slowly along vial wall, not directly on powder

5

Swirl

Roll between palms until dissolved. Never shake.

6

Store

Refrigerate 2–8°C, use within 30 days

Frequently Asked Questions

Yes. Bacteriostatic water (BAC water) is required to reconstitute lyophilized (freeze-dried) peptides. It contains 0.9% benzyl alcohol which prevents bacterial growth, keeping your reconstituted peptide safe for multiple uses over up to 30 days.

Unreconstituted: store at -20°C (freezer) for long-term, or 2–8°C (fridge) for short-term. After reconstitution: always refrigerate at 2–8°C and use within 30 days. Keep away from direct sunlight.

Results vary by individual and protocol. In research settings, measurable effects are typically observed within 1–4 weeks depending on the specific peptide, dosage, and application. Consult a qualified professional for guidance.

Verified suppliers typically include a full third-party COA verifying purity (99%+), identity, and sterility. We recommend only sourcing from vendors that provide batch-specific testing data.

We list verified suppliers above that have been independently reviewed for product quality, testing transparency, and shipping reliability. Always verify COA data before sourcing.

Compound Profile

Scientific data & classification for BPC-157 + TB-500 Blend

Also Known As BPC-157/TB-500 Blend, Wolverine Stack, Healing Blend
Classification Peptide Blend · Tissue Repair
Sequence BPC-157 (15 aa) + TB-500 (43 aa) combined
Molecular Formula Blend - see individual compound profiles
Molecular Weight ~6,383 Da (combined)
CAS Number N/A (blend)
Half-Life Varies by component
Origin Combination of two tissue-repair peptides
Administration Subcutaneous injection
Status Research compound blend
Mechanism of Action Pairs BPC-157's ability to boost blood flow and protect the gut with TB-500's talent for mobilizing repair cells and reducing scar tissue. The two peptides cover complementary healing pathways.
Research Overview The BPC-157 and TB-500 blend represents a combination approach to tissue repair that has gained significant attention in regenerative research for its complementary mechanisms of action. The rationale for combining these two peptides is grounded in their distinct but synergistic biological pathways - BPC-157 primarily drives angiogenesis through upregulation of VEGF, EGF, and other growth factors while modulating the nitric oxide system and dopaminergic pathways, whereas TB-500 operates through actin cytoskeleton regulation to promote cell migration and reduce inflammation via distinct anti-inflammatory cascades. Individually, each peptide has demonstrated substantial tissue-repair capabilities in preclinical models, but the combination aims to address the multifaceted nature of tissue injury more comprehensively than either agent alone. BPC-157's demonstrated effects on tendon, ligament, muscle, bone, and gastrointestinal tissue repair are complemented by TB-500's documented promotion of endothelial cell migration, keratinocyte mobilization, and cardiac progenitor cell activation. From a pharmacological perspective, the blend may benefit from BPC-157's remarkable stability (particularly in the gastrointestinal tract) combined with TB-500's broad tissue distribution as the most abundant intracellular peptide in nucleated cells. Researchers have noted that the two peptides appear to modulate different phases of the wound healing cascade - BPC-157 is particularly active in the proliferative and remodeling phases through its effects on fibroblast function and collagen deposition, while TB-500 plays an earlier role in the inflammatory and migration phases by reducing inflammatory cytokines and establishing chemotactic gradients for repair cells. It should be noted that while both peptides individually have extensive published research, controlled studies evaluating the specific combination and potential pharmacological interactions remain limited, and optimal dosing ratios continue to be an area of active investigation.

Citations

Published findings on BPC-157 + TB-500 Blend from peer-reviewed journals.

Research Assistant
Hey, I'm the PepSpace research assistant. Ask me anything about peptides and I'll do my best to help.